Investment Council: $MKC

Based on Turnaround Radar's research: "McCormick: The Recipe and The Receipt"

McCormick's moat is intact and the standalone business is genuinely cheap — trading at a 40% discount to its own five-year average P/E while earnings are rising. But a pending $44.8 billion merger with Unilever Foods introduces real leverage and integration risk that the current price does not fully resolve, making patience the correct posture until the June 25 Q2 earnings release narrows the range of outcomes.

McCormick's moat shows no signs of erosion. The clearest signal is the four-year margin recovery: adjusted operating margin climbed monotonically from 13.6% in FY2022 to 16.0% in FY2025. Gross margin has stabilized above 37% — the FY2024 peak of 38.5% and the FY2025 dip to 37.4% reflect input-cost volatility, not product commoditization.

Consumer segment revenue grew every year from $3,550M in FY2022 to $3,950M in FY2025 — an 11.3% cumulative increase — with Q1 FY2026 organic growth of +2% characterized as volume- and mix-driven. Pricing power held through the tariff period: Q1 FY2026 revenue of $1.87B beat the $1.79B consensus despite $140M in annual tariff headwinds. McCormick controls roughly 20% of the U.S. spice market after 137 years. No viral brand complaints emerged during a 39% stock decline — brand problems and stock problems are decoupled.

The 39% drawdown is not driven by business deterioration. The stock peaked at $78.16 in June 2025, then fell through three shocks: tariff escalation ($90M→$140M annual burden), the Unilever merger ($44.8B, 4x leverage), and investor backlash (Terry Smith exit). P/E compressed from 26.5x to 15.9x while EPS grew 1.7%.

The crisis is fixable under two paths: merger renegotiation (lower leverage/higher MKC ownership) or shareholder vote rejection (standalone re-rating to 25-27x). The IEEPA tariff ruling creates additional upside not in consensus. The crisis is NOT fixable only if the merger closes as structured and synergies fail while the bridge loan cannot be refinanced.

McCormick's management has demonstrated genuine operational competence: four consecutive years of margin recovery (13.6%→16.0%), orderly CEO succession, and successful integration of Cholula, FONA, and Frank's RedHot in the $400M-$800M range. Guidance credibility is real — beat estimates 3 of 4 quarters, Q1 FY2026 beat on both revenue ($1.87B vs $1.79B) and EPS ($0.66 vs $0.61).

What tempers the verdict is the categorical difference between past acquisitions and the $44.8B Unilever Foods merger — roughly 10x the scale of any prior deal. McCormick shareholders hold only 35% of the combined entity, meaning Foley's team leads integration without majority governance control. Glassdoor at 3.6★ (62% recommend) is below the consumer-staples median — a below-average starting point for merger-driven uncertainty. Management bandwidth risk is real across three simultaneous fronts: tariff mitigation, merger execution, and core business defense.

At $47.80, McCormick's forward P/E of 15.4x represents a 43% discount to its five-year average of ~27x, while EPS grew 1.7%. The compression from 26.5x to 15.9x is a pure multiple contraction event. A conservative re-rating to 22x on $3.09 forward EPS implies $67.98 (+42%). Free cash flow yield is approximately 6.4-6.8%.

Probability-weighted intrinsic value across three scenarios: ~$57 (35% standalone at ~$75.50, 40% revised merger at ~$56.50, 25% as-structured at ~$31.50). The 19% margin of safety is real but the $31.50 left-tail at 25% probability caps conviction. The bridge loan at $15.7B generates $860M-$1.0B in annual interest, putting the Dividend Aristocrat streak at risk in the worst-case scenario.

The moat is intact and the price is cheap — that combination would normally produce a BUY. What holds the Council at WAIT is the Capability and Crisis reports together: the crisis is real but fixable, and the management team is competent but operating at the edge of its demonstrated capability range on a $44.8B transaction that may exceed both its bandwidth and institutional experience.

The verdict is WAIT, not AVOID, because the probability-weighted value is above the current price and the next meaningful data point — Q2 FY2026 earnings on approximately June 25 — is eight weeks away. That is not a long time to wait for substantially more information on a binary outcome.

Toward BUY: Shareholder vote rejects or renegotiates the deal below 3x leverage. Q2 FY2026 operating margin holds above 15.5%. IEEPA tariff refunds materialize, lifting EPS guidance above $3.13. Institutional buyer publicly cites multiple compression as entry point.

Toward AVOID: Merger closes as-structured at 4x+ leverage with no renegotiation and operating margin falls below 13%. Dividend cut announced. Two consecutive quarters of Consumer volume decline while category grows.

Q2 FY2026 earnings (~June 25, 2026): The single most important near-term data point. Watch tariff absorption commentary, operating margin trajectory, guidance revision, and merger vote timing.

Merger vote timeline: H2 2026 vote date, proxy filing, or ISS/Glass Lewis recommendation will shift probability distributions on all three scenarios.

IEEPA refund process: Court of International Trade refund order in place since March 4, 2026. Quantum unknown — any management quantification is a positive catalyst not in current models.

Consumer segment volume: Q1 FY2026 +2% organic growth was volume-driven. Sustaining through Q2 validates the moat thesis and de-risks private-label concerns.

This analysis is research, not investment advice. The TR research it's built on is at turnaroundradar.com. For all current verdicts across the portfolio, see The Verdict Board.